High-dose N-acetylcysteine in an immunocompromised patient with COVID-19 : a case report
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Hong Kong medical journal = Xianggang yi xue za zhi - 30(2024), 1 vom: 07. Feb., Seite 69-71 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lai, K Y [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acetylcysteine |
|---|
| Anmerkungen: |
Date Completed 23.02.2024 Date Revised 23.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.12809/hkmj2210461 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36816392X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36816392X | ||
| 003 | DE-627 | ||
| 005 | 20240229144333.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240208s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.12809/hkmj2210461 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1303.xml |
| 035 | |a (DE-627)NLM36816392X | ||
| 035 | |a (NLM)38327160 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lai, K Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High-dose N-acetylcysteine in an immunocompromised patient with COVID-19 |b a case report |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.02.2024 | ||
| 500 | |a Date Revised 23.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Acetylcysteine | |
| 650 | 4 | |a Adult | |
| 650 | 4 | |a Antioxidants | |
| 650 | 4 | |a COVID-19 | |
| 650 | 7 | |a Acetylcysteine |2 NLM | |
| 650 | 7 | |a WYQ7N0BPYC |2 NLM | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 700 | 1 | |a Au, S Y |e verfasserin |4 aut | |
| 700 | 1 | |a Sin, K C |e verfasserin |4 aut | |
| 700 | 1 | |a Yung, S K |e verfasserin |4 aut | |
| 700 | 1 | |a Leung, A K H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hong Kong medical journal = Xianggang yi xue za zhi |d 1997 |g 30(2024), 1 vom: 07. Feb., Seite 69-71 |w (DE-627)NLM094541337 |x 1024-2708 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:1 |g day:07 |g month:02 |g pages:69-71 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.12809/hkmj2210461 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2024 |e 1 |b 07 |c 02 |h 69-71 | ||